Content - Volume 95, Issue 5
You can find all new content after October 1 on our new website, you can find it
here.
Editor's choice in this issue
EDITORIAL
Anders Vahlquist
REVIEW
Emanual Maverakis, Lynn A. Cornelius, Glen M. Bowen, Tiffany Phan, Falin B. Patel, Sarah Fitzmaurice, Young He, Barbara Burrall, Christopher Duong, April M. Kloxin, Hawa Sultani, Reason Wilken, Steve R. Martinez, Forum Patel
Despite advances in treatment and surveillance, melanoma continues to claim approximately 9,000 lives in the US annually (SEER 2013). The National Comprehensive Cancer Network currently recommends ipilumumab, vemurafenib, dabrafenib, and high-dose IL-2 as first line agents for Stage IV melanoma. Little data exists to guide management of cutaneous and subcutaneous metastases despite the fact that t ...
Pages: 516-524
CLINICAL REPORT
Martin Glatz, Astrid Resinger, Kristina Semmelweis, Christina M. Ambros-Rudolph, Robert R. Müllegger
The spectrum of skin manifestations of Lyme borreliosis in children is not well characterized. We conducted a retrospective study to analyze the clinical characteristics, seroreactivity to Borrelia burgdorferi sensu lato, and outcome after treatment in 204 children with skin manifestations of Lyme borreliosis seen in 1996–2011. Solitary erythema migrans was the most common manifestation (44.6%), ...
Pages: 565-571
CLINICAL REPORT
Laura Huilaja, Kaarin Mäkikallio, Katariina Hannula-Jouppi, Liisa Väkevä, Johanna Höök-Nikanne, Kaisa Tasanen
Gestational pemphigoid, a rare autoimmune skin disease typically occurring during pregnancy, is caused by autoantibodies against collagen XVII. Clinically it is characterised by severe itching followed by erythematous and bullous lesions of the skin. Topical or oral glucocorticoids usually relieve symptoms, but in more severe cases systemic immunosuppressive treatments are needed. Data on immunosu ...
Pages: 593-595
All articles
EDITORIAL
Anders Vahlquist
Page: 515
REVIEW
Emanual Maverakis, Lynn A. Cornelius, Glen M. Bowen, Tiffany Phan, Falin B. Patel, Sarah Fitzmaurice, Young He, Barbara Burrall, Christopher Duong, April M. Kloxin, Hawa Sultani, Reason Wilken, Steve R. Martinez, Forum Patel
Despite advances in treatment and surveillance, melanoma continues to claim approximately 9,000 lives in the US annually (SEER 2013). The National Comprehensive Cancer Network currently recommends ipilumumab, vemurafenib, dabrafenib, and high-dose IL-2 as first line agents for Stage IV melanoma. Little data exists to guide management of cutaneous and subcutaneous metastases despite the fact that t ...
Pages: 516-524
REVIEW
Forum Patel, Sarah Fitzmaurice, Christopher Duong, Young He, Jonathan Fergus, Siba P. Raychaudhuri, Miki Shirakawa Garcia, Emanual Maverakis
Pyoderma gangrenosum (PG) is an inflammatory disease characterized by painful skin ulcerations with undermined and erythematous borders. The etiology of PG is not well understood, but it is generally considered to be an aberrant immune response characterized by a dermal neutrophilc infiltrate. Given the existence of only a few PG clinical trials, treatment options are largely based upon anecdotal ...
Pages: 525-531
INVESTIGATIVE REPORT
Louai A. Salah, Jan Faergemann
Atopic dermatitis (AD) and impetigo are skin conditions where bacterial colonisation and infection, especially with Staphylococcus aureus play an important role. We compared skin bacterial population, resistance patterns and choice of antimicrobial agents in patients diagnosed with AD and impetigo during 2005 and 2011 in our department. Number of positive cultures in the AD group were 40 and 53 in ...
Pages: 532-535
INVESTIGATIVE REPORT
Mireille-Maria Suttle, Mattias Enoksson, Anna Zoltowska, Madhumita Chatterjee, Gunnar Nilsson, Ilkka T. Harvima
A slight epidermal damage can induce the Köbner reaction in psoriasis, and the “alarmin”, interleukin-33 (IL-33), may be involved in this process. Therefore, the uninvolved psoriatic skin was tape-stripped, and skin biopsies were collected at 0d, 2h and 3d or at 0d, 1d and 7d for immunohistochemistry. Eight patients out of 18 with the positive Köbner reaction showed a decrease in epidermal t ...
Pages: 536-541
INVESTIGATIVE REPORT
David Roblin, Gil Yosipovitch, Brent Boyce, John Robinson, James Sandy, Valentina Mainero, Ro Wickramasinghe, Uma Anand, Praveen Anand
Pruritus is an important symptom in psoriasis with no targeted treatment. Tropomyosin-receptor kinase A (TrkA) is associated with pruritus and psoriatic plaque formation. We report the efficacy of a TrkA inhibitor, CT327, on pruritus in psoriasis. A randomised, double-blind, vehicle-controlled Phase 2b clinical trial was conducted in 160 subjects. No effect was found on psoriasis severity using In ...
Pages: 542-548
INVESTIGATIVE REPORT
Noora Neittaanmäki-Perttu, Mari Grönroos, Leila Jeskanen, Ilkka Pölönen, Annamari Ranki, Olli Saksela, Erna Snellman
Lentigo maligna (LM) is an in situ form of melanoma which can progress into invasive lentigo maligna melanoma (LMM). Variations in the pigmentation and thus visibility of the tumour make assessment of lesion borders challenging. We tested hyperspectral imaging system (HIS) in in vivo preoperative delineation of LM and LMM margins. We compared lesion margins delineated by HIS with those estimated c ...
Pages: 549-552
INVESTIGATIVE REPORT
Christian Krüger, Karin U. Schallreuter
Vitiligo is a non-contagious skin disorder with loss of pigmentation, often impairing patients’ well-being. This study used Dermatology Life Quality Index (DLQI), Adjustment to Chronic Skin Disorders Questionnaire (ACS), Beck Depression Inventory (BDI) and additional questions to explore quality of life (QoL), coping, depression and stigmatisation and included 96 patients with vitiligo and 23 co ...
Pages: 553-558
INVESTIGATIVE REPORT
Doris Weiss, Robin Ristl, Johannes Griss, Christine Bangert, Dagmar Foedinger, Georg Stingl, Patrick M. Brunner
Detecting serum-autoantibodies by anti-Desmoglein-1 (anti-Dsg1) and anti-Dsg3 ELISAs as well as indirect immunofluorescence (IIF) are established complementary methods to diagnose pemphigus. Whether autoantibody levels also reflect clinical disease activity is still a matter of debate, as head-to-head comparisons of ELISA values and IIF titres with clinical activity over a longer treatment period ...
Pages: 559-564
CLINICAL REPORT
Martin Glatz, Astrid Resinger, Kristina Semmelweis, Christina M. Ambros-Rudolph, Robert R. Müllegger
The spectrum of skin manifestations of Lyme borreliosis in children is not well characterized. We conducted a retrospective study to analyze the clinical characteristics, seroreactivity to Borrelia burgdorferi sensu lato, and outcome after treatment in 204 children with skin manifestations of Lyme borreliosis seen in 1996–2011. Solitary erythema migrans was the most common manifestation (44.6%), ...
Pages: 565-571
CLINICAL REPORT
Marthe-Lisa Schaarschmidt, Christian Kromer, Raphael Herr, Astrid Schmieder, Sergij Goerdt, Wiebke K. Peitsch
Treatment satisfaction of patients with psoriasis largely depends on the treatment modality, but evidence on preferences for specific medications is scarce. Here we assessed treatment satisfaction of 200 participants with moderate-to-severe psoriasis from a German University hospital with a 5-point scale and the Treatment Satisfaction Questionnaire for Medication (TSQM) and determined sociodemogra ...
Pages: 572-578
CLINICAL REPORT
Toni T Karppinen, Lasse Ylianttila, Hannu Kautiainen, Timo Reunala, Erna Snellman
Empowering heliotherapy aims at clinical healing and improved coping with psoriasis and atopic dermatitis, but evidence of long-term effects is scarce. We studied the effect of 2-week empowering heliotherapy in the Canary Islands on clinical outcome and quality of life in 22 psoriasis and 13 atopic dermatitis patients. Empowerment consisted of meeting peers, sharing experiences and performing phys ...
Pages: 579-582
CLINICAL REPORT
Marléne Isaksson, Sanna Olhardt, Jeanette Rådehed, Åke Svensson
Atopic dermatitis is the most common chronic inflammatory disease among children in industrialised countries. Many factors influence this disease in a negative way and contact allergy is one such factor. The aim of the study was to examine the frequency of contact allergy among children with the diagnosis atopic dermatitis. Contact allergy was found in 22/82 children (26.8%), the most common from ...
Pages: 583-586
CLINICAL REPORT
Ulf Åkerström, Sakari Reitamo, Tor Langeland, Mats Berg, Lisbeth Rustad, Laura Korhonen, Marie Lodén, Karin Wirén, Mats Grände, Petra Skare, Åke Svensson
Atopic dermatitis (AD) affects adults and children and has a negative impact on quality of life. The present multicentre randomized double-blind controlled trial showed a barrier-improving cream (5% urea) to be superior to a reference cream in preventing eczema relapse in patients with AD (hazard ratio 0.634, p=0.011). The risk of eczema relapse was reduced by 37% (95% confidence interval (95% CI ...
Pages: 587-592
CLINICAL REPORT
Laura Huilaja, Kaarin Mäkikallio, Katariina Hannula-Jouppi, Liisa Väkevä, Johanna Höök-Nikanne, Kaisa Tasanen
Gestational pemphigoid, a rare autoimmune skin disease typically occurring during pregnancy, is caused by autoantibodies against collagen XVII. Clinically it is characterised by severe itching followed by erythematous and bullous lesions of the skin. Topical or oral glucocorticoids usually relieve symptoms, but in more severe cases systemic immunosuppressive treatments are needed. Data on immunosu ...
Pages: 593-595
CLINICAL REPORT
Sandrine Benoit, Matthias Goebeler
Treatment of recalcitrant cutaneous lupus erythematosus (CLE) is challenging. In situations where conventional treatment approaches fail mepacrine – an antimalarial/antiinflammatory drug that has fallen into oblivion in the last decades – might still be a promising option. We retrospectively analysed medical records of 10 patients with refractory CLE that were treated with mepacrine (100–200 ...
Pages: 596-599
SHORT COMMUNICATION
Aya Kakizaki, Taku Fujimura, Yumi Kambayashi, Sadanori Furudate, Mitsuko Kawano, Kouetsu Ogasawara, Setsuya Aiba
Abstract is missing (Short communication)
Pages: 600-602
SHORT COMMUNICATION
Valerie C. Amann, Jil Dreier, Desislava Ignatova, Jivko Kamarashev, Katrin Kerl, Werner Kempf, Steve Pascolo, Reinhard Dummer, Antonio Cozzio, Emmanuella Guenova
Abstract is missing (Short communication)
Pages: 602-603
SHORT COMMUNICATION
Sudipta Sinnya, Peter O'Rourke, Emma Ballard, Jean M. Tan, Conrad Morze, Azadeh Sahebian, Sam C. Hames, Tarl W. Prow, Adèle C. Green, H. Peter Soyer
Abstract is missing (Short Communication)
Pages: 604-605
SHORT COMMUNICATION
Tetsuya Honda, Masakatsu Hishizawa, Tatsuki R. Kataoka, Katsuyuki Ohmori, Akifumi Takaori-Kondo, Yoshiki Miyachi, Kenji Kabashima
Abstract is missing (Short communication)
Pages: 606-607
SHORT COMMUNICATION
Ming-Yang Lee, Hui-Jun Wang, Ying Han, Yun Zhou, Jia-Hui Zhao, Li-Na Duo, Cheng Feng, Hong Hua, Hong-Wei Liu, Zhi-Miao Lin, Yong Yang
Abstract is missing (Short communication)
Pages: 608-610
SHORT COMMUNICATION
Hiromasa Matsuda, Naoki Oiso, Norito Ishii, Masako Sato, Megumi Tatebayashi, Takashi Hashimoto, Akira Kawada
Abstract is missing (Short communication)
Pages: 610-611
SHORT COMMUNICATION
Takeshi Kato, Noriki Fujimoto, Gen Nakanishi, Yasuyuki Tsujita, Kazuhiro Matsumura, Yutaka Eguchi, Toshihiro Tanaka
Abstract is missing (Short communication)
Pages: 612-613
SHORT COMMUNICATION
Hiroshi Umemura, Keita Hiragushi, Susumu Sasaki, Hiroko Doi, Naofumi Shiota, Koji Kabutan, Kenji Asagoe
Abstract is missing (short communication)
Pages: 614-615
SHORT COMMUNICATION
Joanna L. Walker, Lisa M. Cohen, George Kroumpouzos
Abstract i missing (Short communication)
Pages: 616-617
SHORT COMMUNICATION
Marie G.H.C. Reinders, Tjinta Brinkhuizen, Patricia M.M.B. Soetekouw, Nicole W.J. Kelleners-Smeets, Myrurgia A. Abdul Hamid, Klara Mosterd
Abstract is missing (Short communication)
Pages: 618-619
SHORT COMMUNICATION
Akitaka Shibata, Kana Tanahashi, Kazumitsu Sugiura, Masashi Akiyama
Abstract is missing (Short communication)
Pages: 620-621
SHORT COMMUNICATION
Alessandro Ostini, Gian Paolo Ramelli, Carlo Mainetti, Mario G. Bianchetti, Alessandra Ferrarini
Abstract is missing (Short communication)
Pages: 622-623
SHORT COMMUNICATION
Natalie Locci-Molina, Annie Wang, George Kroumpouzos
Abstract i missing (Short communication)
Pages: 624-625
SHORT COMMUNICATION
Chien-Chih Wu, Chih-Fen Huang, Li-Jiuan Shen, Fe-Lin Lin Wu
Abstract is missing (Short Communication)
Pages: 626-627
SHORT COMMUNICATION
Masashi Iwata, Hideaki Tanizaki, Hiroko Fujii, Yuichiro Endo, Akihiro Fujisawa, Miki Tanioka, Yoshiki Miyachi, Kenji Kabashima
Abstract is missing (Short communication)
Pages: 628-629
SHORT COMMUNICATION
Makoto Nagai, Hiroshi Nagai, Chiharu Tominaga, Yoshiko Sakaguchi, Orie Jitsukawa, Noriko Ohgo, Chikako Nishigori, Kiyofumi Yamanishi
Abstract is missing (Short communication)
Pages: 629-631
QUIZ
Lidia Maroñas-Jiménez, Diana Menis, Vanessa Gargallo-Moneva, Jose Luis Rodríguez-Peralto, Pablo Luis Ortiz-Romero
Abstract is missing (Quiz)
Pages: 632-638
QUIZ
Jiu-Hong Li, Hao Guo, Song Zheng, Bo Li, Xing-Hua Gao, Hong-Duo Chen
Abstract is missing (Quiz)
Pages: 632-638
QUIZ
Fernando Cammisuli, Vito Catania, Maria Rita Nasca, Andrea Failla, Giuseppe Micali
Abstract is missing (Quiz)
Pages: 632-638
QUIZ
Risa Suzuki, Shiro Niiyama, Yuki Yokouchi, Hideki Mukai
Abstract is missing (Quiz)
Pages: 632-638